MENU
Forex Education Symbols

(ARIX.L)
196.5 -4.5 (-2.24%) 02-23 16:40
Open: 200 Prev Close: 201
High: 200 Low: 195.1
Volume: 13,984 Market Cap: 169M
Year High: 215 Year Low: 167.5
Stock Technical Analysis
Overall       
Targets Six months: 240.49    One year: 280.89
Supports Support1: 191.75   Support2: 183.00
Resistances Resistance1: 205.90    Resistance2: 240.49 
Pivot Point 193.37 
Moving Averages MA(5): 198.30      MA(20): 192.52 

MA(100): 190.56      MA(250): 195.757 
MACD MACD(12,26): 2.27      Signal(12,26,9): 1.30 
Stochastic Oscillator %K(14,3): 83.33      %D(3): 84.81 
RSI RSI(14): 56.99 
52-Week High: 215.00  Low: 167.50  Change(%): -5.5
Average Volume(K) 3-Month: 1605  10-Days: 1754.140015
Moving Averages analysis
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
Bollinger Bands Analysis
ARIX.L has closed below upper band by 33.1%. Bollinger Bands are 37.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Stock News
Arix Bioscience and Ipsen Sign a Strategic Agreement to Develop and ...
Wed, 21 Feb 2018 06:56:15 GMT

Arix Bioscience PLC: CEO Letter to Shareholders
Thu, 04 Jan 2018 14:03:45 GMT

Arix Bioscience leads $30 million financing for Atox Bio
Mon, 04 Dec 2017 07:07:30 GMT

Arix Bioscience PLC: Arix Bioscience co-leads $30 million financing for Aura ...
Thu, 21 Dec 2017 07:07:30 GMT

Is Arix Bioscience plc (LON:ARIX) Cheap And High Growth?
Fri, 02 Feb 2018 16:41:15 GMT

Arix Bioscience leads $45 million Series B financing round into LogicBio ...
Wed, 28 Jun 2017 10:52:30 GMT

Stoxline Canada

Stock Chart London

Option Calculator

Financials
EPS
EPS Est. Current Year
EPS Est. Next Year
EPS Est. Next Quarter
Forward EPS
Shares Out. (M)
Shares Float (M) 3.16
Book Value (p.s.)
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)
Valuation
P/E -4.74
P/E Growth Ratio
P/BV
P/S
P/CF